Literature DB >> 2613329

Protracted necrotizing pharyngitis associated with an acquired defect of neutrophil chemotaxis in multiple myeloma.

K Bergsman1, G Khatib, R Khatib, K Szwajkun.   

Abstract

A 69-year-old man presented with protracted necrotizing pharyngitis requiring prolonged antibiotic therapy. During immunologic evaluation he was found to have IgA multiple myeloma, low complement component C1q and extrinsic defect of neutrophil chemotaxis. The severity of his pharyngitis correlated with myeloma activity implying a causal relationship. The characteristics of the illness strongly suggest that it is related to the acquired defect in neutrophil chemotaxis. This case represents a previously undescribed infectious complication of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613329     DOI: 10.1007/bf01645554

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Phagocytes and C4 in paraproteinaemia.

Authors:  L E Spitler; P Spath; L Petz; N Cooper; H H Fudenberg
Journal:  Br J Haematol       Date:  1975-02       Impact factor: 6.998

2.  Impaired granulocyte adherence in multiple myeloma: relationship to complement system, granulocyte delivery, and infection.

Authors:  R R MacGregor; W G Negendank; A D Schreiber
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

3.  Infections complicating multiple myeloma and chronic lymphocytic leukemia.

Authors:  J J Twomey
Journal:  Arch Intern Med       Date:  1973-10

4.  Current patterns of infection in multiple myeloma.

Authors:  B R Meyers; S Z Hirschman; J A Axelrod
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

5.  Infections in patients with multiple myeloma.

Authors:  C W Norden
Journal:  Arch Intern Med       Date:  1980-09

6.  Defective neutrophil chemotaxis in juvenile periodontitis.

Authors:  R A Clark; R C Page; G Wilde
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Studies on the pathogenesis of an immune defect in multiple myeloma.

Authors:  T Paglieroni; M R MacKenzie
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

8.  Defective opsonization in multiple myeloma.

Authors:  B D Cheson; R R Plass; G Rothstein
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

9.  Alternative pathway of complement in multiple myeloma.

Authors:  E H Kraut; A L Sagone
Journal:  Am J Hematol       Date:  1981-12       Impact factor: 10.047

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.